Clinical trials in Mali
210 studies list at least one site in Mali. 17 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the studies in Mali recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Most studied here
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (63) · London School of Hygiene and Tropical Medicine (11) · ANRS, Emerging Infectious Diseases (9) · University of Maryland, Baltimore (7) · Serum Institute of India Pvt. Ltd. (6) · GlaxoSmithKline (5) · French Africa Pediatric Oncology Group (4) · University Clinical Research Center, Mali (4)
What changed recently
From the registry's own updates since Oct 11, 2026.
Results posted1
Studies
Recruiting first, then most recently updated. Showing 50 of 210 — search for more.
- The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United StatesRecruitingNCT07027826Not applicable
- Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, MaliRecruitingNCT01168271
- Study of Inherited Neurological DisordersRecruitingNCT00004568
- Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine CandidatesRecruitingNCT02471378
- Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali.RecruitingNCT07758985Phase 1
- BPH Global RegistryRecruitingNCT05543200
- PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in MaliRecruitingNCT07675785Phase 2
- Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate VaccineRecruitingNCT07379151
- Microbiome and Atopy in MaliRecruitingNCT07051902
- Pregnancy Registry in MaliRecruitingNCT06468319
- Therapeutic Recommendations For The Treatment Of Children With A RetinoblastomaRecruitingNCT04425434
- Recommendations for the Treatment of Children With Burkitt's LymphomaRecruitingNCT04425421
- Therapeutic Recommendations for NephroblastomaRecruitingNCT04423484
- Safety of Antimalarials in the FIRst trimEsterRecruitingNCT06962319Phase 3
- Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking AfricaRecruitingNCT03803735
- Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West AfricaRecruitingNCT06860178Phase 4
- A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy InfantsRecruitingNCT05447377Phase 3
- Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum MalariaCompletedNCT05842954Phase 3
- Attractive Targeted Sugar Bait Trial in MaliCompletedNCT04149119Not applicable
- L9LS in Women of Childbearing Potential in MaliCompletedNCT07060508Phase 2
- Improving HPV Vaccination Coverage Among Adolescent Girls in Mali and Côte d'Ivoire Through Community Health Worker Follow-upCompletedNCT07807202Not applicable
- Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)CompletedNCT05312918
- Variants of SARS-CoV-2 Causing COVID-19 in AfricaCompletedNCT05311891
- L9LS MAb in Malian InfantsCompletedNCT06461026Phase 1
- Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)WithdrawnNCT05652504Phase 1
- Prevalence and Incidence of Lassa Virus Infection in Southern MaliCompletedNCT03783143
- Oral Azithromycin to Prevent Stillbirths and Infant Mortality in MaliActive, not recruitingNCT03909737Phase 4
- Pfs230D1 + R21 in Matrix-M1 in African School Children and AdultsActive, not recruitingNCT07147400Phase 2
- Trivalent Salmonella Conjugate Vaccine (TSCV)Active, not recruitingNCT05784701Phase 2
- Investigation of Immune Amnesia Following Measles Infection in Select African RegionsCompletedNCT06153979
- Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT04546633Phase 2
- Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)CompletedNCT03459157Not applicable
- Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan AfricaCompletedNCT02626286Not applicable
- L9LS-R21 InteractionWithdrawnNCT07208760Phase 2
- Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI VaccinesCompletedNCT05155579Phase 1
- Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate VaccineCompletedNCT05093829Phase 3
- Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in MaliActive, not recruitingNCT06080243Phase 2
- Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African AdultsCompletedNCT06507605Phase 1
- Safety, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in MaliCompletedNCT06413108Phase 1/2
- International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)CompletedNCT05096091
- Study of COVID-19 Outbreak in Hospital Departments of Bamako, MaliCompletedNCT04710316Not applicable
- Anti-malaria MAb in Malian ChildrenCompletedNCT05304611Phase 2
- hands4health: A Multi-component Intervention on Hand Hygiene in Primary Health Care Facilities in Burkina Faso and MaliCompletedNCT05946980Not applicable
- Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month OldsCompletedNCT03295318Phase 2
- Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in MaliCompletedNCT04424511Phase 3
- Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their InfantsCompletedNCT03589768Phase 2
- SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)CompletedNCT03806452Phase 2
- Chlorproguanil-Dapsone in Pregnant WomenTerminatedNCT00126971Phase 1
- Safety and Efficacy of CIS43LS Anti-malaria mAb in MaliCompletedNCT04329104Phase 2
- L9LS MAb in Malian AdultsCompletedNCT05816330Phase 2